Browsing Harvard Medical School by Keyword "Amyloid-β"
Now showing items 1-2 of 2
-
Immunotherapy for Alzheimer’s disease: hoops and hurdles
(BioMed Central, 2013)Alzheimer’s disease (AD) is the most common form of dementia, afflicting more than 30 million people worldwide. Currently, there is no cure or way to prevent this devastating disease. Extracellular plaques, containing ... -
Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges
(BioMed Central, 2016)Immunization against amyloid-β (Aβ) peptides deposited in Alzheimer’s disease (AD) has shown considerable therapeutic effect in animal models however, the translation into human Alzheimer’s patients is challenging. In ...